Cleveland Clinic led a trial that found a left atrial appendage closure (LAAC) may be an effective alternative to taking blood thinners for those with atrial fibrillation. Walid Saliba, MD speaks with Oussama Wazni, MD, Section Head of Cardiac Electrophysiology and Pacing at Cleveland Clinic and Primary Investigator of the OPTION Trial. The question they wanted to answer with this trial was if LAAC would safely reduce bleeding rates while maintaining low stroke rates compared to blood thinners after atrial fibrillation ablation.

Learn more about the Atrial Fibrillation Center
https://my.clevelandclinic.org/departments/heart/depts/atrial-fibrillation-center

Learn more about the Atrial Fibrillation Stroke Prevention Center
https://my.clevelandclinic.org/departments/heart/depts/atrial-fibrillation-stroke-prevention-center